Current stock page

Stock Analysis

JCI (JCI) Stock Analysis

JCI (JCI) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

JCI Stock Analysis Summary

JCI (JCI) currently has an AIQ Score of 54/100, indicating a neutral setup. Momentum is the strongest factor at 64/100. Value is the weakest current factor at 38/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Oct 30, 2026 · Market-close data

JCI at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$149.03
AIQ Score54/100
Overall ViewNeutral
Technical Analysis ConsensusStrong Buy
Market Cap$84.35B
P/E Ratio (TTM)24.13
Forward P/E—
EPS (quarter ended 2026-06-30)$1.23
Revenue (quarter ended 2026-06-30)$6.61B
Dividend Yield (TTM)1.15%
Beta1.32
Volume4.65M
52-week range$108.41-$160.41
RSI 1450.95
50-Day SMA$147.27
200-Day SMA$140.92
Analyst Price Target—
Next Earnings—
As of Oct 30, 2026 · Market close

JCI

Low Priority

Above Peers

NeutralEdge 6/10
$149.03−$9.24 (−5.84%)

Latest quote

  • Momentum
    64
  • Value
    38
  • Quality
    63
  • Risk resilience
    49
  • Sentiment
    —
algovestiq.comScore data as of Oct 30, 2026

JCI Stock Analysis Summary

JCI (JCI) currently has an AIQ Score of 54/100, indicating a neutral setup. Momentum is the strongest factor at 64/100. Value is the weakest current factor at 38/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Oct 30, 2026 · Market-close data
AIQ Composite Posture: Mixed

In a neutral regime, JCI has AIQ Score of 54/100 with Momentum base of 64/100 and fading Value at 38/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Momentum (64/100) leads while Value (38/100) lags. This cross-factor spread creates entry timing uncertainty.

Sector · -5.84% stock move · JCI classified in its covered industry.

Current Evidence

NeutralJCI is in a neutral AIQ regime; Momentum is the strongest visible factor at 64/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is JCI Bullish or Bearish Right Now?

JCI currently has a neutral overall setup. Momentum is the strongest factor at 64/100, while Value is weakest at 38/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.

Bull Case
  • - Quality is supportive at 63/100.
  • - Momentum is constructive at 64/100.
  • - Price is +7.47% above its 50-day SMA.
  • - Technical consensus has more buy votes than sell votes (34 vs 8).
Bear Case
  • - Value is the current constraint at 38/100.

Current Consensus

JCI's Technical Analysis Consensus is currently Strong Buy, with 34 buy, 3 neutral, and 8 sell votes. JCI's 14-day RSI is 50.95, which places the stock in a neutral momentum range. JCI's beta is 1.32, indicating greater market sensitivity than the broad market.

Signal Confidence
High agreement

What Changed in JCI?

The largest recent change in JCI is Momentum moving up by 34.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.

AIQ Score
+9.0
Momentum
+34.0
Quality
+0.0
Risk
-1.0

What Would Change the JCI Outlook?

The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

JCI Decision Framework

Public evidence layers, setup checks, and risk context for JCI.

JCI (JCI) Stock Analysis

JCI has an AIQ Score of 54/100 in a Neutral regime. Momentum is strongest at 64/100. Beta is not shown in the current snapshot. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextJCI is in a Neutral AIQ regime with score 54/100.
Signal ConflictThe primary conflict is that momentum leads at 64/100 while value lags at 38/100.
Factor EvidenceMomentum 64/100 · Value 38/100 · Quality 63/100 · Risk 49/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthWait

Momentum is the strongest factor at 64/100.

TimingWait

Momentum is 64/100 and RSI (14) is 51.0.

Regime fitWait

JCI is in a Neutral regime at 54/100.

Risk controlWait

Risk factor is 49/100 and annual volatility 32.24%.

ConflictWait

Current conflict: momentum leads at 64/100 while value lags at 38/100.

AIQ Score
54/100
Price
$149.03
Beta
—
RSI (14)
51

JCI Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

JCI Fundamentals

JCI valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$6.61B
Net income
$749M
Free cash flow
$1.5B
View full JCI fundamental analysis

JCI Technical Analysis

JCI technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Strong Buy
RSI 14
50.95
Price vs SMA-50
+7.47%
View full JCI technical analysis

JCI Stock Catalysts

Track JCI earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
—
Analyst target
—
News items
0
View JCI earnings and stock catalysts

JCI Dividend Analysis

JCI dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
1.07%
Annual dividend
$1.60
Payout ratio
—
View JCI dividend history and analysis

JCI Financial Data

JCI revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$6.61B
EPS
$1.23
Periods
3
View JCI financials

JCI Risk Analysis

JCI volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
1.32
Risk score
49/100
1Y volatility
32.24%
View JCI risk analysis

JCI Stock News

JCI stock news, market tone, recent headlines, and catalyst context.

News items
0
Updated
—
Sentiment
—
Read JCI stock news

About the AIQ Score

Methodology for the current stock evidence.

As of Oct 30, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a JCI stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

3 recent quarterly periods are available for review.

Checked Oct 31, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
29.7
As of Jun 30, 2026
Revenue growth
—
Gross margin
0.37%
Current debt / equity
0.7
Latest quarterly evidence

Latest period Jun 30, 2026.

Review fundamentals
Quarter revenue
$6.61B
Quarter net income
$749M
Quarter free cash flow
$1.5B

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Bullish
Momentum
Mixed
RSI 14
50.95
MACD
1.33

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
49/100
Beta
—
Annual volatility
32.24%
Max drawdown
-12.98%

JCI Stock FAQ

What is JCI stock price today?

JCI's current stock price is $149.03. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is JCI bullish or bearish right now?

JCI's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is JCI's market cap?

JCI's market cap is $84.35B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is JCI's current P/E ratio?

JCI's current P/E ratio is 24.13 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is JCI's RSI?

JCI's 14-day RSI is 50.95 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is JCI above its 50-day and 200-day moving averages?

JCI is 7.47% from its 50-day SMA and 12.31% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is JCI's next earnings date?

JCI's next earnings date is a key event to check before making a decision. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does JCI pay a dividend?

JCI's dividend yield is 1.15% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.